Katelyn Arnold works at the interface of glycobiology and pharmaceutical chemistry. She develops quantitative LC-MS assays with isotopic calibrants, chemoenzymatically builds defined glycans, and studies their pharmacokinetics and immunothrombotic activity in animal models to inform biomarkers and therapeutics.